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Abstract 
Ingestion of monosodium glutamate (MSG) has been shown to cause headaches in healthy 
individuals and trigger migraine-like headaches in migraine sufferers. We combined 
immunohistochemistry, in vivo electrophysiology, and laser Doppler recordings of dural 
vasculature to investigate the effect of systemic administration of MSG on the 
trigeminovascular pathway. Immunohistochemical analysis confirmed the expression of NMDA 
receptors on nerve fibres innervating dural blood vessels and excitatory amino acid transporter 
2 on dural blood vessels.  Systemic administration of MSG (50 mg/kg) evoked an increase in 
ongoing discharge in 5/6 spinal trigeminal subnucleus caudalis (SpVc) neurons with dural input 
recorded from male and female rats, respectively, as well as lowering their mechanical 
*Manuscript (Clear Copy)
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
activation threshold. There were no sex-related differences in these effects of MSG.  Neuronal 
discharge and mechanical sensitization were significantly attenuated by co-injection with the 
peripherally restricted NMDA receptor antagonist (2R)-amino-5-phosphonovaleric acid in both 
sexes.  Systemic administration of MSG induced a 24.5% and 20.6% increase in dural flux in 
male and female rats, respectively. These results suggest that MSG-induced headache is 
mediated by the activation of peripheral NMDA receptors and subsequent dural vasodilation. 
Peripheral NMDA receptors are a potential target for the development of new drugs to treat 
headaches.  
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Introduction  
The pathophysiology of migraine has yet to be fully elucidated, however, the excitation of 
trigeminal afferent fibres which innervate the dura and converge at the spinal trigeminal 
subnucleus caudalis (SpVc), has been identified as a key mechanism in headache pain (Burstein 
et al., 2015). Historically, migraine has been considered a vascular headache, largely based on 
the observation of dilation of retinal and temporal blood vessels during a migraine attack 
(Goltman, 1936; Wolff et al., 1953). Recent studies are conflicting in their support of a vascular 
mechanism in migraine attacks (Friberg et al., 1991; Zwetsloot et al., 1993; Kruuse et al., 2003; 
Asghar et al., 2010). Dural blood vessels are heavily innervated by trigeminal afferent fibres, 
however, and several scenarios exist which could lead to excitation of afferents and also 
vasodilation during a migraine attack. In the first scenario, dilation of the highly innervated 
dural blood vessels can activate trigeminovascular afferent fibres, potentially leading to the 
sensitization of the trigeminovascular system (Levy and Burstein, 2011). In the second scenario, 
dural afferent fibres which have already been activated may induce vasodilation via neurogenic 
inflammation by releasing calcitonin gene related peptide (CGRP) and substance P (SP) in (Levy 
and Burstein, 2011). 
Glutamate, an excitatory neurotransmitter, has been linked to migraine pathophysiology for 
several reasons. Glutamate levels in blood plasma, platelets, and cerebrospinal fluid (CSF) are 
elevated in migraineurs long after a migraine attack (Martinez et al., 1993; Cananzi et al., 1995; 
Eufemia et al., 1997), and several genetic variants affecting glutaminergic neurotransmission 
have been identified in migraine sufferers (Schürks, 2012; Burstein et al., 2015). Glutamate is 
also well known to be involved in the sensitization of trigeminal afferent fibres (Cairns et al., 
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2007; Gazerani et al., 2010b; Laursen et al., 2014), as well as the transduction of nociceptive 
signaling (Klafke et al., 2012; Chan and MaassenVanDenBrink, 2014).  Monosodium glutamate 
(MSG) is a naturally occurring form of glutamic acid, and is an International Headache Society 
recognized trigger for headache. MSG-related headache is classified as mild to moderate in 
non-migraineurs, but classified as episodic migraine in those who suffer from migraine 
(Headache Classification Committee of the International Headache Society, 2013).  In recent 
studies, a single oral dose of 150mg/kg taken consecutively for five days resulted in headache 
and muscle tenderness when given to healthy young volunteers (Baad-Hansen et al., 2010; 
Shimada et al., 2013, 2015), which merit further studies as to the mechanism of MSG. 
It is unknown how elevated levels of glutamate contribute to headache. Because glutamate 
does not cross the blood-brain-barrier (BBB) (Gasparini and Griffiths, 2013), ingestion of MSG 
likely induces headache through a peripheral mechanism. To investigate the potential 
mechanisms by which MSG may induce headache, we assessed (i) the expression the NMDA 
receptor and glutamate transporters in the dura, as well as (ii) the neuronal and (iii) vascular 
effects of systemic administration of MSG in rats. We also assessed whether co-administration 
of a peripherally restricted NMDA receptor antagonist, (2R)-amino-5-phosphonovaleric (APV), 
could attenuate effects of MSG administration on SpVc neurons.  
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
5 
 
Experimental procedures 
Animals:  
Male (305–480 g, n=30) and female (245-330 g, n=28) Sprague Dawley rats (Charles River, 
Canada) were used for these experiments.  Animals were housed in groups of two or three and 
were subject to a 12-h light/dark cycle.  Food and water were available ad libitum. All animal 
procedures were reviewed and approved by the University of British Columbia Animal Care 
Committee. 
Surgical Procedure for Electrophysiological and Doppler Recordings:  
Male and female Sprague-Dawley rats were anaesthetised with isoflurane (2-2.5% in oxygen 97-
98%) and artificially ventilated via a trachea tube. Temperature was continually measured with 
a rectal thermometer and maintained at 37±0.5°C using a heating pad (Fine Science Tools, 
Vancouver, Canada). Blood pressure was measured via carotid artery cannulation. The heart 
rate, blood pressure, and core body temperature were monitored throughout the experiments.  
The femoral vein was cannulated to administer drugs. Animals were placed in a Kopf stereotaxic 
frame, and the skull was exposed.  
For electrophysiology experiments, the right parietal and the frontal bone were removed from 
the lambdoid suture to anterior of the orbit. An incision was also made in the skin and muscle 
over the neck to expose the brainstem, the dura was removed and a C1 laminectomy was 
performed. The exposed brainstem was bathed in mineral oil. 
A separate group of animals were used for dural blood flow experiments. The closed window 
method was used to measure dural blood flux with a Doppler flowmeter (Akerman et al., 2013). 
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Briefly, the parietal bone was thinned over the middle meningeal artery (MMA) using a small 
drill, creating a “closed window”. The Doppler probe was held in place over the window by a 
cotton-tipped applicator lowered in position by a micro manipulator. Mineral oil was used to 
keep the cotton-tipped applicator and exposed bone moist.  
Electrophysiological Recordings:  
Extracellular action potentials of SpVc neurons with dural receptive fields were recorded with a 
parylene-coated tungsten microelectrode (0.010”, 2MΩ, A-M Systems Inc., Carlsborg, WA, USA) 
in male (n=21) and female (n=19) rats. The recording electrode was lowered into the exposed 
brainstem over the spinal subnucleus caudalis (SpVc), 1-2mm lateral and 1-2mm caudal to the 
obex and at depth ranging from 50-2800 μm at a 33˚ angle. The V1 and V2 dermatomes of the 
skin were brushed while the electrode was lowered. To identify potential areas of the SpVc 
which may have dural input, mechanoreceptors innervating the dura were identified by their 
response to mechanical stimulation applied to the dura. . Mechanoreceptors innervating the 
dura were identified by their response to mechanical stimulation applied to the dura.  An 
electronic von Frey hair (model 1601C, Life Science, USA) was used to assess the mechanical 
activation threshold for dural responsive SpVc neurons.  In some experiments multiple neurons, 
which could be differentiated by their action potential characteristic, shared a dural receptive 
field; in those cases, the acquired data from both neurons were used and spike sorting was 
applied with Spike 2 software (Cambridge Electronics, UK). The neurons were characterized by 
their receptive fields, their response to innocuous (brush) and noxious (pinch) stimuli applied to 
the skin, and also the latency to action potential discharge following electrical stimulation of 
the dura (0.5-5 mA, 0.5 ms, 0.5 Hz).  In addition, the response of neurons to direct mechanical 
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stimulation of the temporalis muscle with a blunt probe was determined by temporarily pulling 
the skin away from the muscle. 
Following the identification of a SpVc neuron with a dural receptive field, the baseline 
mechanical threshold (MT) was measured. Briefly, the von Frey hair was pressed against the 
dural receptive field with increasing force until it elicited an action potential discharge; the 
smallest force which elicited an action potential was recorded as the MT. The mean baseline 
MT was calculated from five evoked responses separated by one minute intervals. A five-
minute baseline was recorded to assess ongoing discharge in the neuron, after which 50mg 
MSG was administered alone or in combination with APV (5mg/kg or 50mg/kg). Post-injection 
discharge was monitored for 5 minutes.  Cumulative discharge was calculated by subtracting 
the number of action potentials during the pre-injection period from those during the post-
injection period.  The criterion for neuronal activation was a positive difference between the 
total number of action potentials fired following MSG administration and action potentials fired 
during the baseline period. The MT was then assessed for a period of 10 minutes. Mean MT 
values were calculated for the two 5-minute post-injection time periods. Animals were 
euthanized at the end of the experiments (pentobarbital 100 mg/kg). 
Laser Doppler Recordings:  
Five male and five female Sprague Dawley rats were used to measure relative changes in dural 
blood flow following MSG administration. Dural blood flux (measured in perfusion units, PU) 
was sampled at a rate of 1Hz. A 30-minute recovery period was allocated following the 
completion of surgery, before beginning the dural blood flux recording, because the surgical 
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procedures might have altered meningeal blood flow. The laser Doppler fibre-optic probe was 
placed perpendicular to the dura over a branch of the MMA. The emitted laser light penetrates 
to a depth of 1mm. Thus, the signal recorded emanates primarily from blood flow through the 
MMA. The Doppler probe was calibrated in a polystyrene calibration solution prior to each use 
and mineral oil was applied once the probe was held in position over the closed window to 
minimize noise. After the recovery period, a five-minute baseline measurement of dural blood 
flux was recorded, followed by systemic injection of 50mg/kg MSG, which was flushed with 
0.5ml of normal saline.  Animals were euthanized at the end of experiments (pentobarbital 100 
mg/kg). 
Drugs: 
L-glutamic acid sodium salt hydrate (Sigma Aldrich) was dissolved in water to a final 
concentration of 169.1mg/ml and administered at doses of 50mg/kg. This dose of MSG has 
been found to mechanically sensitize rat masseter muscle afferent fibres (Cairns et al., 2007). 
Fresh solutions of MSG were prepared weekly. DL-2-Amino-5-phosphonovaleric Acid (APV, 
Santa Cruz Biotechnology) was dissolved in 0.2M NaOH and phosphate buffered saline (PBS, 
Sigma Aldrich). Two concentrations of APV were prepared, 20mg/ml and 2mg/ml which were 
administered at doses of 50mg/kg and 5mg/kg, respectively. The experimenter was blinded to 
the dose of APV being administered.  
Immunohistochemistry:  
Male (n=4) and female (n=4) rats were anaesthetised and perfused with cold saline followed by 
paraformaldehyde (4%). The head of the rat was placed in 20% sucrose followed by 40% 
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sucrose for 48 hours each to dehydrate the tissue. Whole mount tissue samples were stained 
with antibodies against protein gene product 9.5 (rabbit polyclonal 1:1500, Abcam) and von 
Willebrand Factor (sheep polyclonal 1:750, Cedarlane), to identify nerve fibres and blood 
vessels, respectively. All tissues were also incubated with antibodies against the NR2B subunit 
of the NMDA receptor (NMDAr; mouse monoclonal 1:400, Abcam).  The expression of 
excitatory amino acid transporters 1-3 (EAAT1-3; sheep polyclonal 1:250, Santa Cruz) was also 
assessed.  Tissue staining was done as described previously (Dong et al., 2007; Sung et al., 
2008; Laursen et al., 2014). Tissues were visualized with Leica TCS SPE high resolution spectral 
confocal microscope (Leica DM 2500, Canada) equipped with a digital camera (Leica DFC310 FX, 
Canada) and the Leica application suite software (Version 2.3.6, build 5381). Images were taken 
in the x-y plane and z-stacking was used to view the tissue within 3-dimensions.  
Statistical Analysis:  
An ANOVA sample size estimation suggested that groups of 6 animals were sufficient to detect 
an effect of MSG in electrophysiology experiments (α = 0.05, power = 0.80). The median change 
in neuronal discharge in the MSG group and MSG+APV (5 or 50mg/kg) groups were compared 
using a 2-way ANOVA on ranks with sex and treatment as factors. The Holm-Sidak test was used 
post-hoc. The mean of the relative MT was calculated for the two post drug time points for 
each treatment group. Three-way repeated measures ANOVA was performed on the relative 
MT at the two different time points with sex and treatment as factors. The Fisher’s least 
significant difference (LSD) test was used post-hoc. 
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Results 
Expression of Glutamate Receptors and Transporters in the Dura:  
While glutamate has been proposed to play a role in neurogenic inflammation and excitation of 
trigeminal afferent fibres, the expression of glutamate receptors in the dura has not been 
assessed. Histological analysis revealed that NMDArs are expressed by nerve fibers innervating 
dural blood vessels (Figure 1). The receptor expression was localized to nerve endings rather 
than along axons distal to blood vessels. The expression of glutamate transporters EAAT1-3 was 
also assessed, however, only EAAT2 was identified on dural blood vessels (Figure 1).  The 
expression of the NMDA receptor led to the use of the NMDA receptor antagonist, APV, in 
electrophysiology experiments.  
 
Characteristics of SpVc neurons with dural input:   
To determine the potential effect of MSG and APV (0, 5, 50 mg/kg) on the spontaneous and 
evoked activity of SpVc neurons with dural receptive fields, electrophysiological recordings 
from 36 neurons were undertaken (Figure 2). All neurons had receptive fields on the dura and 
most (34, 94%) also had additional receptive fields on the face. Receptive fields were 
predominantly located in the V1 (ophthalmic) dermatome, most commonly around the eye, but 
also could include both V1 and V2 (maxillary) dermatomes. The majority of neurons received 
input from both the skin (86%) and the temporalis muscle (89%; V3).  Ninety-two percent of 
neurons were classified as wide-dynamic range (WDR), responding to both innocuous (brush) 
and noxious (pinch) stimuli, the remaining were classified as either nociceptive specific (NS, 5%) 
or low threshold (LT, 3%). Response to electrical stimulation of the dural receptive field was 
assessed in 25 neurons, 10 (40%) of these neurons responded with a mean latency of 11.8 ± 2.2 
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ms. The neurons recorded in this experiment have similar characteristics to wide dynamic range 
SpVc neurons reported in other studies (Akerman and Goadsby, 2015).  
MSG activates and sensitizes trigeminovascular neurons:  
The intravenous administration of 50mg/kg MSG induced an increase in the activity of SpVc 
neurons. An example of the responses from SpVc neurons to MSG is shown in Figure 3A and B.  
In 5/6 male and 5/6 female rats, MSG evoked an increase in neuronal discharge (males: 
0.44±0.32 Hz; females: 0.89±0.41 Hz) when compared with the baseline spontaneous activity 
(males: 0.09±0.07 Hz; females: 0.75±0.37 Hz) (Figure 3C). The median increase in the number of 
action potentials fired following MSG administration was 11 and 25 for male and female rats, 
respectively. 
Mechanical sensitization of SpVc neurons was assessed by measuring mechanical thresholds 
prior to and after intravenous administration of 50mg/kg MSG. The changes induced in 
mechanical thresholds measured in male and female rats after injection of MSG are shown in 
Figure 4A. Two relative MTs were calculated, at 5-10 minutes and 10-15 minutes post MSG 
administration.  In male rats, MSG induced a mean (±SE) 11.1 ± 5.7% decrease in MT, while in 
female rats the effect was smaller with a 0.4 ± 12.5% decrease in MT, 5-10 minutes after 
receiving MSG. The mechanical sensitization induced by MSG during the first five minute period 
returned to baseline values during the 10-15 minute period.  
                   
APV attenuates the activation and sensitization induced by MSG:  
Co-administration of 5mg/kg, but not 50mg/kg APV, with MSG resulted in a statistically 
significant decrease in the median discharge following drug administration (p= 0.015, 2-way 
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ANOVA on RANKS, post-hoc Holm-Sidak). There was no statistically significant difference when 
male and female rats were compared (Figure 3D). 
The combination of 50mg/kg APV with MSG induced a 21.2 ± 15.0% and 37.6 ± 15.4% increase 
in MT in male and female rats, respectively at 5-10 minutes post injection. At 10-15 minutes 
after the drug administration, the relative MT in the 50mg/kg APV + MSG treated animals had 
increased by 43.0 ± 30.6% and 67.8 ± 12.1% in male and female rats, respectively. The relative 
MTs of animals treated with MSG and 50mg/kg APV are statistically different from those who 
received MSG alone (p=0.010, 3-way rm ANOVA, post-hoc Fisher’s least significant difference 
test). The relative mechanical thresholds from 10-15 minutes post drug administration are 
larger than those measured at 5-10 minutes post drug administration (p=0.014, 3-way repeated 
measures ANOVA).  There was not a statistically significant difference in MTs between male and 
female rats. The effects of MSG administered alone or combined with APV on mechanical 
threshold are shown in Figure 4 B.  
MSG induces dural vasodilation:  
To determine whether MSG evoked activation and sensitization of SpVc neurons was associated 
with dural vasodilation, laser Doppler flowmetry was used to assess the dural flux in response 
to systemic administration of MSG in male (n=5) and female (n=5) rats.   Figure 5 depicts an 
experimental trace of the MSG induced effect on dural flux and blood pressure.  A mean 
maximal increase of 24.5 ± 4.4 % and 20.6 ± 2.8 % in the dural flux, relative to baseline, was 
measured in male and female rats, respectively. The duration of the MSG evoked surge in flux 
was approximately 170s in both sexes.  Systemic blood pressure also increased but this began 
several seconds after the increase in dural flux.  
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Discussion  
Consumption of MSG can induce a headache in normal healthy individuals and a migraine-like 
headache in migraineurs (Anon, 2013). MSG was first implicated in the 1960s to cause a 
number of adverse effects including muscle pain and weakness, cutaneous flushing, heart 
palpations and headache (Ambos et al., 1968; Schaumburg et al., 1969). The symptoms were 
originally called ‘Chinese restaurant syndrome’ but later renamed ‘MSG symptom complex’. 
Subsequent studies on ‘MSG symptom complex’ concluded that MSG consumption did not 
induce symptoms of pain or sensitivity, even in ‘MSG sensitive patients’, but many of these 
studies have been scrutinized for their poor methodology (Tarasoff and Kelly, 1993; Geha et al., 
2000). More recent studies have found that oral or intravenous administration of MSG induces 
headache, muscle sensitivity and increased systolic blood pressure in healthy volunteers 
(Graham et al., 2000; Baad-Hansen et al., 2010; Shimada et al., 2013, 2015).  
We propose that headache and pain associated with MSG consumption are mediated, in part, 
through activation of peripheral NMDArs . While the expression of NMDArs and transporters 
has been assessed in the TG (Larsen et al., 2014; Wong et al., 2014), little is known about their 
expression in the dura. Immunohistochemical analysis of the dura revealed the expression of 
the NMDAr on densely innervated dural blood vessels. The findings also revealed that EAAT2, 
but not EAAT1 or 3, were expressed in association with dural blood vessels. In the CNS, EAAT2 is 
expressed in astrocytes (Danbolt, 2001; Zhou and Danbolt, 2013), thus it is possible that EAAT2 
is being expressed on glial cells near the surface of blood vessels in the dura. Inhibited 
clearance of glutamate by EAAT2 in the dura could affect sensory transmission by afferent 
fibres in migraine patients (Laursen et al., 2014). The effect of inhibiting EAAT1/2 in the TG on 
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the excitability of temporalis or masseter muscle afferents in rats has recently be assessed 
(Laursen et al., 2014).  Co-administration of EAAT1/2 inhibitor TFB-TBOA ((3S)-3-[[3-[[4-
(trifluoromethyl)benzoyl]amino]phenyl]methoxy]-l-aspartic acid) and glutamate into the TG 
increased glutamate evoked neuronal discharge (Laursen et al., 2014). A genetic mutation in 
the gene that encodes EAAT2 has been linked to migraine (12), thus inhibited clearance of 
glutamate at the level of the dura may act to sensitize meningeal afferent fibres in migraineurs. 
These data suggest that elevated blood concentrations of glutamate could act on NMDArs 
expressed by dural vascular tissues. 
Excitation of trigeminal afferent fibres that innervate the dura and converge on the SpVc is 
thought to be a critical mechanism in migraine pathophysiology (Burstein et al., 2015). In this 
study, administration of 50mg/kg MSG induced both activation, as measured by an increase in 
neuronal discharge, and sensitization of SpVc neurons to mechanical stimulation of the dura. 
The excitation induced by MSG in the present study was attenuated when APV was co-
administered. Interestingly, co-administration of APV with MSG not only reversed MSG-induced 
mechanical sensitization but actually appeared to increase the mechanical activation threshold 
of SpVc neurons with dural receptive fields.  One interpretation of this result is that dural 
afferent mechanical sensitivity is dependent on the local release of glutamate, perhaps from 
the terminal endings of dural afferent fibres, as has been found for the temporalis muscle 
(Gazerani et al., 2010a). The co-administration of 50mg/kg APV with MSG also resulted in a 
decrease in neuronal discharge below that of the baseline values, which may reflect basal 
neuronal activation due to blood glutamate. As APV is thought to be peripherally restricted 
(Lodge et al., 1988; Whitten et al., 1990), these results suggest that the effects of MSG on SpVc 
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neurons are mediated by peripheral NMDA receptors, however, because a relatively high dose 
was used it cannot be ruled out that a small amount of APV crossed the BBB (Lodge et al., 
1988).  
We also determined that MSG’s ability to excite SpVc neurons was associated with increased 
blood perfusion through the medial meningeal artery.  This effect likely reflects a combination 
of increased blood pressure and local vasodilation.  Glutamate and NMDA applied to the pia, 
induced vasodilation of pial vessels in newborn pigs that was blocked by L-NNA (NG-nitro-L-
arginine), a potent nitric oxide synthetase inhibitor (Meng et al., 1995). This suggests that the 
glutamate induced dural vasodilation may be mediated by an increase of nitric oxide (NO), 
which is a potent vasodilator (Garthwaite, 1991; Meng et al., 1995). Intramuscular injections of 
glutamate in rats increase muscle blood flow for up to 30 minutes, which is attenuated with co-
injections of kynurenic acid, APV, or a CGRP receptor antagonist (Cairns et al., 2003; Gazerani et 
al., 2010a), suggesting that the glutamate induced muscular vasodilation may be mediated by 
peripheral NMDA and non-NMDA receptors, through the release of CGRP (Jackson and 
Hargreaves, 1999; Gazerani et al., 2010a). The potent vasodilatory actions of CGRP have been 
implicated in migraine pathogenesis (Gazerani et al., 2010a; Burstein et al., 2015).  Additional 
studies will be required to determine if MSG-induced dural vasodilation is mediated by 
activation of peripheral NMDArs. 
In the present study, a sex-related difference in either neuronal discharge or mechanical 
sensitization induced by MSG administration was not identified. In previous electrophysiological 
experiments in rats, a sex-related difference in neuronal discharges evoked by glutamate was 
found.  Intramuscular injections of glutamate into the masseter muscle provoked a larger 
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increase in discharge of trigeminal afferent fibers in female than in male rats (Cairns et al., 
2001). Similarly, women seem to respond more profoundly to MSG than men. Early 
experiments aimed at understanding mechanisms of ‘MSG symptoms complex’ found that 
women were more responsive to oral MSG than men and that men needed a higher dose to 
provoke a negative effect of MSG  (Ambos et al., 1968; Tarasoff and Kelly, 1993). When injected 
subcutaneously into the forehead or intramuscularly into the masseter muscle, glutamate also 
evoked a higher pain rating score in women than men (Cairns et al., 2001; Svensson et al., 2003; 
Gazerani et al., 2006). The present study may have been underpowered to resolve a sexually 
dismorphic response of SpVc neurons to MSG.  
Elevated levels of glutamate during and after migraine attacks (Martinez et al., 1993; Cananzi et 
al., 1995; Eufemia et al., 1997), genetic variants which alter glutamate homeostasis (Schürks, 
2012), and the ability of MSG to induce a migraine-like attack in migraineurs rather than a mild-
moderate headache (Anon, 2013), all suggest that glutamate may play a critical role in migraine 
headache pathophysiology.  Previous findings also suggest that glutamate regulation may be an 
important mechanism in botulinum neurotoxin type A (BoNTA) migraine prophylaxis (Gazerani 
et al., 2010a). Pretreatment with BoNTA decreased interstitial glutamate concentrations in the 
temporalis muscle of rats and also prevented glutamate induced vasodilation and mechanical 
sensitivity (Gazerani et al., 2010a). These findings suggest that tissue glutamate concentrations 
are important for regulating the sensitivity of mechano-nociceptors, and that elevated 
concentrations of glutamate in the blood may be a cause rather than a consequence of 
migraine headache. 
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Conclusion  
The present results suggest that MSG-induced headache could be mediated by the activation of 
peripheral NMDArs and subsequent dural vasodilation. The MSG induced sensitization of SpVc 
neurons with input from the dura and face correlate with clinical observations of allodynia and 
headache following the administration of MSG in humans.  The findings merit further studies 
into the relationship between EAAT dysfunction, glutamate regulation, and the mechanisms 
underlying headache and migraine. The results also suggest peripheral NMDArs are a potential 
target for the development of new drugs to treat headaches. 
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Figure Legends 
 
Figure 1: Photomicrographs in A and B show expression of EAAT2 and NMDArs on dural blood 
vessels and within the dura. The small box on the composite shows a region of interest which 
has been magnified to the right for each fluorphore.  In A, blood vessels are identified by the 
expression of von Willebrand Factor (vWF), and are innervated by nerve fibres (PGP 9.5), which 
express the NR2B subunit.   In B, a number of nerve fibers are shown.  Note that the nerve fiber 
in the region of interest is positively labelled for the NMDA receptor, and also weakly labeled 
for EAAT2.  Calibration bar (small box): 25 m; Yellow arrows: blood vessels; White arrows: 
nerve fibers. 
 
Figure 2: An electronic von Frey hair was used to determine the MTs of SpVc neurons with dural 
receptive fields, before and after administration of MSG alone or in combination with APV. A, 
experimental set-up for electrophysiological recordings of SpVc neurons. Blue areas on the 
exposed dura represent common dural receptive fields of the neurons recorded. B, method to 
record and calculate mechanical threshold (MT) from SpVc neurons. At one minute intervals 
throughout the recording, mechanical pressure was applied using the electronic von Frey 
instrument to the dural receptive field until an action potential (top trace) was fired. The lowest 
magnitude of mechanical pressure (bottom trace) required to generate an AP from this neuron 
was taken as its MT. C, facial receptive fields of the SpVc neurons recorded, darker blue 
represents the most common facial receptive field which includes the temporalis muscle and 
periorbital skin. 
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Figure 3: MSG induced an increase of neuronal discharge which was attenuate by co-
administration of APV. In A and B, peri-stimulus histograms depict the increase in frequency 
(spikes/sec) of action potentials evoked from individual SpVc neurons following administration 
of 50mg/kg MSG (injected at 300s).  The peristimulus histograms of A and B show a neuron that 
was quiet or had on-going activity prior to the administration of MSG, respectively. C, the total 
number of action potentials (neuronal discharge) recorded before and after administration of 
MSG (n=6 males, 6 females). D, the median cumulative discharge following administration of 
MSG + APV (0, 5, 50mg/kg, n=6). The asterisk indicates a statistically significant difference 
between the 5mg/kg APV treated groups (male + female) and 0mg/kg APV treated groups (male 
+ female) (P<0.05, post-hoc Holm-Sidak multiple comparison test). There was not a statistically 
significant difference based on sex (P=0.142). 
 
Figure 4: A.  The relative mechanical threshold at 10 and 15 minutes post administration of 
MSG is shown (n=6 males, 6 females).  The dotted line indicates no change in threshold.  B.  Co-
administration of APV attenuated the MSG induced mechanical sensitization of SpVc neurons at 
10 and 15 minutes post drug administration (n=6).   Asterisks indicate thresholds significantly 
different between 50mg/kg APV + MSG and MSG treatment groups (p<0.05, post-hoc Fisher’s 
LSD test). There was not a statistically significant difference based on sex.  
 
Figure 5: An experimental trace showing the response to 50mg/kg MSG administered 
intravenously in a male rat. Flux, measured in perfusion units (PU), and blood pressure, 
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measured in mmHg, both increase transiently following MSG administration (at 300s, dotted 
line). 
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